Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Capper

Showing results (151-160 of 350) with videos related to

Pageof 35
Sort By:
Acta Neuropathologica|September 7, 2018
Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastomaDamian Stichel, Azadeh Ebrahimi, David Reuss, et al.
The Oncologist|April 8, 2026
Comprehensive molecular analyses for diagnosis and treatment guidance in an adult neuroblastoma patientDamian T Rieke, Stefan Schwartz, Sebastian Ochsenreither, et al.
BMC Cancer|May 16, 2020
Acquired resistance to DZNep-mediated apoptosis is associated with copy number gains of AHCY in a B-cell lymphoma modelChidimma Agatha Akpa, Karsten Kleo, Elisabeth Oker, et al.
Acta Neuropathologica|November 18, 2025
Rare IDH hotspot mutations in dysembryoplastic neuroepithelial tumors expand the spectrum of IDH-altered CNS tumorsMartin Raby, Euphrasie Servant, Volodia Dangouloff-Ros, et al.
Neuro-Oncology|December 7, 2013
A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07)Markus Hutterer, Martha Nowosielski, Johannes Haybaeck, et al.
Neuro-Oncology|October 11, 2023
Mean global DNA methylation serves as independent prognostic marker in IDH-wildtype glioblastomaAlicia Eckhardt, Richard Drexler, Melanie Schoof, et al.
Klinische Padiatrie|June 24, 2026
Guidance for the Diagnosis and Treatment of Rare Embryonal and Sarcomatous Brain Tumors-a Report from the Central Nervous System-International Registry for Rare Embryonal and Sarcomatous Tumors German Society of Pediatric Oncology and Hematology Study GroupPascal Johann, Dominik Sturm, Rolf Kortmann, et al.
Scientific Reports|April 18, 2025
Association of phosphorylation status of ERK and genetic MAPK alterations in pediatric tumorsFlorian Selt, Romain Sigaud, Andrey Korshunov, et al.
Acta Neuropathologica|June 26, 2009
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomasChristian Hartmann, Jochen Meyer, Jörg Balss, et al.
Brain Pathology (Zurich, Switzerland)|December 10, 2016
CASP9 germline mutation in a family with multiple brain tumorsMichael W Ronellenfitsch, Ji-Eun Oh, Kaishi Satomi, et al.
Pageof 35

Showing results (151-160 of 350) with videos related to

Sort By:
Pageof 35
Acta Neuropathologica|September 7, 2018
Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastomaDamian Stichel, Azadeh Ebrahimi, David Reuss, et al.
The Oncologist|April 8, 2026
Comprehensive molecular analyses for diagnosis and treatment guidance in an adult neuroblastoma patientDamian T Rieke, Stefan Schwartz, Sebastian Ochsenreither, et al.
BMC Cancer|May 16, 2020
Acquired resistance to DZNep-mediated apoptosis is associated with copy number gains of AHCY in a B-cell lymphoma modelChidimma Agatha Akpa, Karsten Kleo, Elisabeth Oker, et al.
Acta Neuropathologica|November 18, 2025
Rare IDH hotspot mutations in dysembryoplastic neuroepithelial tumors expand the spectrum of IDH-altered CNS tumorsMartin Raby, Euphrasie Servant, Volodia Dangouloff-Ros, et al.
Neuro-Oncology|December 7, 2013
A single-arm phase II Austrian/German multicenter trial on continuous daily sunitinib in primary glioblastoma at first recurrence (SURGE 01-07)Markus Hutterer, Martha Nowosielski, Johannes Haybaeck, et al.
Neuro-Oncology|October 11, 2023
Mean global DNA methylation serves as independent prognostic marker in IDH-wildtype glioblastomaAlicia Eckhardt, Richard Drexler, Melanie Schoof, et al.
Klinische Padiatrie|June 24, 2026
Guidance for the Diagnosis and Treatment of Rare Embryonal and Sarcomatous Brain Tumors-a Report from the Central Nervous System-International Registry for Rare Embryonal and Sarcomatous Tumors German Society of Pediatric Oncology and Hematology Study GroupPascal Johann, Dominik Sturm, Rolf Kortmann, et al.
Scientific Reports|April 18, 2025
Association of phosphorylation status of ERK and genetic MAPK alterations in pediatric tumorsFlorian Selt, Romain Sigaud, Andrey Korshunov, et al.
Acta Neuropathologica|June 26, 2009
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomasChristian Hartmann, Jochen Meyer, Jörg Balss, et al.
Brain Pathology (Zurich, Switzerland)|December 10, 2016
CASP9 germline mutation in a family with multiple brain tumorsMichael W Ronellenfitsch, Ji-Eun Oh, Kaishi Satomi, et al.
Pageof 35